Buscar
Mostrando ítems 1-10 de 1040
Prevention, management, and rehabilitation of stroke in low- and middle-income countries
(Elsevier, 2016)
Although stroke incidence in high-income countries (HICs) decreased over the past four decades, it increased dramatically in low- and middle-income countries (LMICs). In this review, we describe the current status of primary ...
Characterization of patients with embolic strokes of undetermined source in the navigate esus randomized trial
(Elsevier, 2018-06)
Background: The New Approach Rivaroxaban Inhibition of Factor Xa in a Global Trial vs. ASA to Prevent Embolism in Embolic Stroke of Undetermined Source (NAVIGATE-ESUS) trial is a randomized phase-III trial comparing ...
Trends in the burden of stroke in Mexico: A national and subnational analysis of the global burden of disease 1990–2019
(Elsevier, 2022)
Background: Scarce epidemiological information on stroke in Mexico impedes evidence-based decisions and debilitates the design of effective prevention programmes at the local level. Methods: Ecological and secondary analysis ...
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
(Sage Publications, 2016)
Background: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The
stroke recurrence rate is substantial with aspirin, widely used for secondary prevention. The New
Approach riVaroxaban ...
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial
(Sage Publications, 2016)
Background: Embolic strokes of undetermined source comprise up to 20% of ischemic strokes. The
stroke recurrence rate is substantial with aspirin, widely used for secondary prevention. The New
Approach riVaroxaban ...
Stroke: causes and clinical features
Stroke is a clinically defined syndrome of acute, focal neurological
deficit attributed to vascular injury (infarction, haemorrhage) of the
central nervous system. Stroke is the second leading cause of death
and disability ...
Long-term Adherence to National Guidelines for Secondary Prevention of Ischemic Stroke: A Prospective Cohort Study in a Public Hospital in Chile
(Elsevier, 2014)
Background Clinical guidelines for the secondary prevention of ischemic stroke have been developed, but their publication is insufficient to make them effective. Our aim was to investigate adherence to Chilean guidelines, ...
Long-term Adherence to National Guidelines for Secondary Prevention of Ischemic Stroke: A Prospective Cohort Study in a Public Hospital in Chile
(Elsevier, 2014)
Background Clinical guidelines for the secondary prevention of ischemic stroke have been developed, but their publication is insufficient to make them effective. Our aim was to investigate adherence to Chilean guidelines, ...
A stepwise approach to stroke surveillance in Brazil: the EMMA (Estudo de Mortalidade e Morbidade do Acidente Vascular Cerebral) study
(WILEY-BLACKWELLNEW YORK, 2010)
Background Stroke mortality rates in Brazil are the highest in the Americas. Deaths from cerebrovascular disease surpass coronary heart disease. Aim To verify stroke mortality rates and morbidity in an area of Sao Paulo, ...
Symptomatic Neonatal Arterial Ischemic Stroke: The International Pediatric Stroke Study
(AMER ACAD PEDIATRICS, 2011)
BACKGROUND: Neonatal arterial ischemic stroke (AIS) has emerged as a leading cause of perinatal brain injury, cerebral palsy, and lifelong disability. The pathogenesis is poorly understood, which limits the development of ...